A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
Clinical trial NCT07560124 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07560124
- Sponsor
- Akeso
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-06
- Primary completion
- 2028-06-06
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.